MediRita Company
AI for drug discovery.
Industry:
Early Drug Development
Estimated Revenue:
Less than $1M
Technology:
Artificial Intelligence, Biotechnology, Pharmaceutical
Headquarters:
Mapo, Seoul-t'ukpyolsi, South Korea
Investor Type:
For Profit
Founded Date:
2018-06-04